ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, Chaowagul W, Day NP, Peacock SJ, 2010. Increasing incidence of human melioidosis in northeast Thailand. Am J Trop Med Hyg 82: 1113–1117.
-
2.
Currie BJ, Fisher DA, Howard DM, Burrow JN, Selvanayagam S, Snelling PL, Anstey NM, Mayo MJ, 2000. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 74: 121–127.
-
3.
Limmathurotsakul D, Wuthiekanun V, Chierakul W, Cheng AC, Maharjan B, Chaowagul W, White NJ, Day NP, Peacock SJ, 2005. Role and significance of quantitative urine cultures in diagnosis of melioidosis. J Clin Microbiol 43: 2274–2276.
-
4.
Walsh AL, Smith MD, Wuthiekanun V, Suputtamongkol Y, Chaowagul W, Dance DA, Angus B, White NJ, 1995. Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis 21: 1498–1500.
-
5.
Walsh AL, Wuthiekanun V, 1996. The laboratory diagnosis of melioidosis. Br J Biomed Sci 53: 249–253.
-
6.
Chaowagul W, Chierakul W, Simpson AJ, Short JM, Stepniewska K, Maharjan B, Rajchanuvong A, Busarawong D, Limmathurotsakul D, Cheng AC, Wuthiekanun V, Newton PN, White NJ, Day NP, Peacock SJ, 2005. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis. Antimicrob Agents Chemother 49: 4020–4025.
-
7.
Chaowagul W, Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, White NJ, 1999. A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin Infect Dis 29: 375–380.
-
8.
Cheng AC, Limmathurotsakul D, Chierakul W, Getchalarat N, Wuthiekanun V, Stephens DP, Day NP, White NJ, Chaowagul W, Currie BJ, Peacock SJ, 2007. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis 45: 308–314.
-
9.
Chierakul W, Anunnatsiri S, Short JM, Maharjan B, Mootsikapun P, Simpson AJ, Limmathurotsakul D, Cheng AC, Stepniewska K, Newton PN, Chaowagul W, White NJ, Peacock SJ, Day NP, Chetchotisakd P, 2005. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis 41: 1105–1113.
-
10.
Wuthiekanun V, Limmathurotsakul D, Wongsuvan G, Chierakul W, Teerawattanasook N, Teparrukkul P, Day NP, Peacock SJ, 2007. Quantitation of B. pseudomallei in clinical samples. Am J Trop Med Hyg 77: 812–813.
-
11.
Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ, 2003. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163: 2066–2072.
-
12.
Baughman RP, Kerr MA, 2003. Ventilator-associated pneumonia patients who do not reduce bacteria from the lungs have a worse prognosis. J Intensive Care Med 18: 269–274.
-
13.
Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, Rajanuwong A, Wuthiekanun V, Howe PA, Walsh AL, Chaowagul W, White NJ, 1999. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 29: 381–387.
-
14.
Suputtamongkol Y, Rajchanuwong A, Chaowagul W, Dance DA, Smith MD, Wuthiekanun V, Walsh AL, Pukrittayakamee S, White NJ, 1994. Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis. Clin Infect Dis 19: 846–853.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 345 | 315 | 42 |
| Full Text Views | 307 | 10 | 1 |
| PDF Downloads | 64 | 8 | 1 |
Repeat Blood Culture Positive for B. pseudomallei Indicates an Increased Risk of Death from Melioidosis
Direk Limmathurotsakul
Direk Limmathurotsakul
Department of Tropical Hygiene, Department of Microbiology and Immunology and Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine and Department of Clinical Pathology, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom; Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom
Search for other papers by Direk Limmathurotsakul in
Current site
Google Scholar
PubMed
Search for other papers by Direk Limmathurotsakul in
Current site
Google Scholar
PubMed
Vanaporn Wuthiekanun
Vanaporn Wuthiekanun
Department of Tropical Hygiene, Department of Microbiology and Immunology and Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine and Department of Clinical Pathology, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom; Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom
Search for other papers by Vanaporn Wuthiekanun in
Current site
Google Scholar
PubMed
Search for other papers by Vanaporn Wuthiekanun in
Current site
Google Scholar
PubMed
Gumphol Wongsuvan
Gumphol Wongsuvan
Department of Tropical Hygiene, Department of Microbiology and Immunology and Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine and Department of Clinical Pathology, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom; Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom
Search for other papers by Gumphol Wongsuvan in
Current site
Google Scholar
PubMed
Search for other papers by Gumphol Wongsuvan in
Current site
Google Scholar
PubMed
Sukanya Pangmee
Sukanya Pangmee
Department of Tropical Hygiene, Department of Microbiology and Immunology and Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine and Department of Clinical Pathology, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom; Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom
Search for other papers by Sukanya Pangmee in
Current site
Google Scholar
PubMed
Search for other papers by Sukanya Pangmee in
Current site
Google Scholar
PubMed
Premjit Amornchai
Premjit Amornchai
Department of Tropical Hygiene, Department of Microbiology and Immunology and Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine and Department of Clinical Pathology, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom; Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom
Search for other papers by Premjit Amornchai in
Current site
Google Scholar
PubMed
Search for other papers by Premjit Amornchai in
Current site
Google Scholar
PubMed
Prapit Teparrakkul
Prapit Teparrakkul
Department of Tropical Hygiene, Department of Microbiology and Immunology and Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine and Department of Clinical Pathology, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom; Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom
Search for other papers by Prapit Teparrakkul in
Current site
Google Scholar
PubMed
Search for other papers by Prapit Teparrakkul in
Current site
Google Scholar
PubMed
Nittaya Teerawattanasook
Nittaya Teerawattanasook
Department of Tropical Hygiene, Department of Microbiology and Immunology and Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine and Department of Clinical Pathology, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom; Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom
Search for other papers by Nittaya Teerawattanasook in
Current site
Google Scholar
PubMed
Search for other papers by Nittaya Teerawattanasook in
Current site
Google Scholar
PubMed
Nicholas P. J. Day
Nicholas P. J. Day
Department of Tropical Hygiene, Department of Microbiology and Immunology and Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine and Department of Clinical Pathology, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom; Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom
Search for other papers by Nicholas P. J. Day in
Current site
Google Scholar
PubMed
Search for other papers by Nicholas P. J. Day in
Current site
Google Scholar
PubMed
Sharon J. Peacock
Sharon J. Peacock
Department of Tropical Hygiene, Department of Microbiology and Immunology and Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Medicine and Department of Clinical Pathology, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand; Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom; Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom
Search for other papers by Sharon J. Peacock in
Current site
Google Scholar
PubMed
Search for other papers by Sharon J. Peacock in
Current site
Google Scholar
PubMed
Melioidosis, a bacterial infection caused by Burkholderia pseudomallei, is notoriously difficult to cure despite appropriate antimicrobial therapy and has a mortality rate of up to 40%. We demonstrate that a blood culture positive for B. pseudomallei taken at the end of the first and/or second week after hospitalization for melioidosis is a strong prognostic factor for death (adjusted odds ratio = 4.2, 95% confidence interval = 2.1–8.7, P < 0.001 and adjusted odds ratio = 2.6, 95% confidence interval = 1.1–6.0, P = 0.03, respectively). However, repeat cultures of respiratory secretions, urine, throat swabs, or pus/surface swabs provide no prognostic information. This finding highlights the need for follow-up blood cultures in patients with melioidosis.
Author Notes
Financial support: This study was supported by the Wellcome Trust.
Authors' addresses: Direk Limmathurotsakul, Department of Tropical Hygiene and Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, E-mail: direk@tropmedres.ac. Vanaporn Wuthiekanun, Gumphol Wongsuvan, Sukanya Pangmee, and Premjit Amornchai, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, E-mails: lek@tropmedres.ac, gumphol@tropmedres.ac, sukanya@tropmedres.ac, and kung@tropmedres.ac. Prapit Teparrakkul, Department of Medicine, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand, E-mail: prapith_11@hotmail.com. Nittaya Teerawattanasook, Department Clinical Pathology, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand, E-mail: nidteerawa@hotmail.com. Nicholas P. J. Day, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand and Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, United Kingdom, E-mail: nickd@tropmedres.ac. Sharon J. Peacock, Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, United Kingdom, and Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge CB2 0SP, United Kingdom, E-mail: sharon@tropmedres.ac.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, Chaowagul W, Day NP, Peacock SJ, 2010. Increasing incidence of human melioidosis in northeast Thailand. Am J Trop Med Hyg 82: 1113–1117.
-
2.
Currie BJ, Fisher DA, Howard DM, Burrow JN, Selvanayagam S, Snelling PL, Anstey NM, Mayo MJ, 2000. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 74: 121–127.
-
3.
Limmathurotsakul D, Wuthiekanun V, Chierakul W, Cheng AC, Maharjan B, Chaowagul W, White NJ, Day NP, Peacock SJ, 2005. Role and significance of quantitative urine cultures in diagnosis of melioidosis. J Clin Microbiol 43: 2274–2276.
-
4.
Walsh AL, Smith MD, Wuthiekanun V, Suputtamongkol Y, Chaowagul W, Dance DA, Angus B, White NJ, 1995. Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis 21: 1498–1500.
-
5.
Walsh AL, Wuthiekanun V, 1996. The laboratory diagnosis of melioidosis. Br J Biomed Sci 53: 249–253.
-
6.
Chaowagul W, Chierakul W, Simpson AJ, Short JM, Stepniewska K, Maharjan B, Rajchanuvong A, Busarawong D, Limmathurotsakul D, Cheng AC, Wuthiekanun V, Newton PN, White NJ, Day NP, Peacock SJ, 2005. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis. Antimicrob Agents Chemother 49: 4020–4025.
-
7.
Chaowagul W, Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, White NJ, 1999. A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin Infect Dis 29: 375–380.
-
8.
Cheng AC, Limmathurotsakul D, Chierakul W, Getchalarat N, Wuthiekanun V, Stephens DP, Day NP, White NJ, Chaowagul W, Currie BJ, Peacock SJ, 2007. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis 45: 308–314.
-
9.
Chierakul W, Anunnatsiri S, Short JM, Maharjan B, Mootsikapun P, Simpson AJ, Limmathurotsakul D, Cheng AC, Stepniewska K, Newton PN, Chaowagul W, White NJ, Peacock SJ, Day NP, Chetchotisakd P, 2005. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis 41: 1105–1113.
-
10.
Wuthiekanun V, Limmathurotsakul D, Wongsuvan G, Chierakul W, Teerawattanasook N, Teparrukkul P, Day NP, Peacock SJ, 2007. Quantitation of B. pseudomallei in clinical samples. Am J Trop Med Hyg 77: 812–813.
-
11.
Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ, 2003. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163: 2066–2072.
-
12.
Baughman RP, Kerr MA, 2003. Ventilator-associated pneumonia patients who do not reduce bacteria from the lungs have a worse prognosis. J Intensive Care Med 18: 269–274.
-
13.
Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, Rajanuwong A, Wuthiekanun V, Howe PA, Walsh AL, Chaowagul W, White NJ, 1999. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 29: 381–387.
-
14.
Suputtamongkol Y, Rajchanuwong A, Chaowagul W, Dance DA, Smith MD, Wuthiekanun V, Walsh AL, Pukrittayakamee S, White NJ, 1994. Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis. Clin Infect Dis 19: 846–853.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 345 | 315 | 42 |
| Full Text Views | 307 | 10 | 1 |
| PDF Downloads | 64 | 8 | 1 |